BHCM
AGIO icon

Brevan Howard Capital Management’s Agios Pharmaceuticals AGIO Stock Holding History

Brevan Howard Capital Management’s Portfolio AGIO Stock Details AGIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$867K Buy
24,469
+5,133
+27% +$146K 0.01% 984
2025
Q4 		$526K Buy
19,336
+7,265
+60% +$255K 0.01% 1086
2025
Q3 		$485K Sell
12,071
-17,106
-59% -$643K 0.01% 1304
2025
Q2 		$970K Buy
+29,177
New +$884K 0.01% 1075
2025
Q1 		– Sell
-47,326
Closed -$1.56M – 1131
2024
Q4 		$1.56M Buy
47,326
+36,599
+341% +$1.72M 0.04% 330
2024
Q3 		$477K Sell
10,727
-3,102
-22% -$141K 0.02% 693
2024
Q2 		$596K Sell
13,829
-2,507
-15% -$90.5K 0.04% 547
2024
Q1 		$478K Sell
16,336
-2,208
-12% -$59.1K 0.04% 481
2023
Q4 		$413K Buy
+18,544
New +$416K 0.04% 569

Other funds holding AGIO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $15.3B AUM 50.95% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AC
Armistice Capital New York $3.03B AUM 36.06% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $127B AUM 43.98% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $86.1B AUM 29.11% 1-Year Est. Return